Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. DBV Technologies
  6. Summary
    DBV   FR0010417345

DBV TECHNOLOGIES

(DBV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
07/21/2021 07/22/2021 07/23/2021 07/26/2021 07/27/2021 Date
8.894(c) 8.744(c) 9.364(c) 9.19(c) 8.91(c) Last
170 731 115 181 242 577 164 470 184 900 Volume
+5.13% -1.69% +7.09% -1.86% -3.05% Change
More quotes
Estimated financial data (e)
Sales 2021 8,08 M 9,56 M 9,56 M
Net income 2021 -102 M -120 M -120 M
Net cash position 2021 91,9 M 109 M 109 M
P/E ratio 2021 -5,02x
Yield 2021 -
Sales 2022 17,3 M 20,5 M 20,5 M
Net income 2022 -103 M -122 M -122 M
Net Debt 2022 9,57 M 11,3 M 11,3 M
P/E ratio 2022 -5,59x
Yield 2022 -
Capitalization 489 M 579 M 579 M
EV / Sales 2021 49,2x
EV / Sales 2022 28,8x
Nbr of Employees 104
Free-Float 91,2%
More Financials
Company
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to... 
Sector
Pharmaceuticals
Calendar
08/02Earnings Release
More about the company
Ratings of DBV Technologies
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about DBV TECHNOLOGIES
07/26DBV TECHNOLOGIES : to Report First Half 2021 Financial Results and Business Upda..
GL
07/23European ADRs Move Higher in Friday Trading
MT
07/12European ADRs Move Higher in Monday Trading
MT
07/08European ADRs Move Sharply Lower in Thursday Trading
MT
07/01DBV TECHNOLOGIES S A : Files for Up to $250 Million Shelf
MT
06/23DBV TECHNOLOGIES : AGM 2021 – Minutes of the Annual General Meeting
PU
06/22European ADRs Move Lower in Tuesday Trading
MT
06/14European ADRs Move Higher in Monday Trading
MT
06/09European ADRs Slightly Higher Wednesday With Biotechs Leading While Miners Dr..
MT
06/02GLOBAL MARKETS LIVE : Tesla, AB Volvo, Credit Suisse, Amazon, Tyson Foods...
06/01DBV TECHNOLOGIES : to Present at Upcoming Investor Conferences
PU
05/28European ADRs Move Higher in Friday Trading
MT
05/26European ADRs Trading Nearly Flat Wednesday; IDEX a Standout
MT
05/24DBV TECHNOLOGIES : I.—CHARACTERISTIC FEATURES OF THE COMPANY (Form 8-K)
PU
05/24DBV TECHNOLOGIES S.A. : Amendments to Articles of Inc. or Bylaws; Change in Fisc..
AQ
More news
News in other languages on DBV TECHNOLOGIES
07/26DBV TECHNOLOGIES : présente ses résultats financiers du premier semestre 2021 et..
07/20DBV TECHNOLOGIES : plus forte baisse du SBF 120 à la clôture du mardi 20 juillet..
07/06DBV TECHNOLOGIES : AGM 2021 – Procès-Verbal de l'Assemblée Générale Annuel..
06/23DBV TECHNOLOGIES : AGM 2021 – Procès Verbal de l'Assemblée Générale Annuel..
06/22DBV TECHNOLOGIES : plus forte baisse du SBF 120 à la clôture du mardi 22 juin 20..
More news
Analyst Recommendations on DBV TECHNOLOGIES
More recommendations
Chart DBV TECHNOLOGIES
Duration : Period :
DBV Technologies Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DBV TECHNOLOGIES
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 8,91 €
Average target price 11,30 €
Spread / Average Target 26,8%
EPS Revisions
Managers and Directors
Daniel TassÚ Chief Executive Officer & Executive Director
SÚbastien Robitaille Chief Financial Officer
Michel de Rosen Non-Executive Chairman
Pharis Mohideen Chief Medical Officer
Pascal Wotling Chief Technical Operations Officer
Sector and Competitors